Bhanji Muna

CIK 00018469054 companiesWALTHAM, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001846905

Recent Transactions

50 trades

Award
ARDELYX, INC.$ARDX
Stock Option (Right to Buy)
2026-06-16+39,715→ 39,715 total
Award
ARDELYX, INC.$ARDX
Common Stock
2026-06-16+26,455→ 163,808 total
Award
VERACYTE, INC.$VCYT
Common Stock
2026-06-11+5,272→ 44,582 total
Award
Intellia Therapeutics, Inc.$NTLA
Common Stock
2026-06-09+9,200→ 36,403 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2026-06-09+13,300→ 13,300 total
Award
CYTOKINETICS INC$CYTK
Common Stock
2026-05-27+2,851→ 26,361 total
Award
CYTOKINETICS INC$CYTK
Non-Qualified Stock Option (Right to Buy)
2026-05-27+4,301→ 4,301 total
Award
VERACYTE, INC.$VCYT
Common Stock
2025-06-18+9,321→ 39,310 total
Award
ARDELYX, INC.$ARDX
Stock Option (Right to Buy)
2025-06-18+54,059→ 54,059 total
Award
ARDELYX, INC.$ARDX
Common Stock
2025-06-18+41,551→ 137,353 total
Sale
VERACYTE, INC.$VCYT
Common Stock
2025-06-13$26.67/sh−4,589→ 29,989 total
Award
Intellia Therapeutics, Inc.$NTLA
Common Stock
2025-06-11+8,000→ 27,203 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2025-06-11+11,450→ 11,450 total
Sale
CYTOKINETICS INC$CYTK
Common Stock
2025-05-15$29.73/sh−1,454→ 23,510 total
Award
CYTOKINETICS INC$CYTK
Common Stock
2025-05-14+7,333→ 24,964 total
Award
CYTOKINETICS INC$CYTK
Non-Qualified Stock Option (Right to Buy)
2025-05-14+10,880→ 10,880 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2025-04-29$8.50/sh−265→ 19,203 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2025-01-29$9.97/sh−265→ 19,468 total
Award
ARDELYX, INC.$ARDX
Stock Option (Right to Buy)
2024-06-14+40,243→ 40,243 total
Award
VERACYTE, INC.$VCYT
Common Stock
2024-06-13+11,473→ 34,578 total
Award
Intellia Therapeutics, Inc.$NTLA
Common Stock
2024-06-12+7,737→ 19,733 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2024-06-12+11,515→ 11,515 total
Sale
VERACYTE, INC.$VCYT
Common Stock
2024-06-10$20.32/sh−3,870→ 23,105 total
Sale
CYTOKINETICS INC$CYTK
Common Stock
2024-06-10$52.07/sh−2,000→ 17,631 total
Sale
VERACYTE, INC.$VCYT
Common Stock
2024-05-28$21.00/sh−1,539→ 26,975 total
Award
CYTOKINETICS INC$CYTK
Non-Qualified Stock Option (Right to Buy)
2024-05-15+3,636→ 3,636 total
Award
CYTOKINETICS INC$CYTK
Common Stock
2024-05-15+5,600→ 19,631 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2023-10-31$23.90/sh−265→ 11,996 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2023-07-31$42.33/sh−265→ 12,261 total
Sale
CYTOKINETICS INC$CYTK
Common Stock
2023-07-07$34.12/sh−2,000→ 14,031 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2023-07-06$39.30/sh−1,867→ 12,526 total
Sale
VERACYTE, INC.$VCYT
Common Stock
2023-06-16$27.09/sh−100→ 28,514 total
Sale
VERACYTE, INC.$VCYT
Common Stock
2023-06-16$26.42/sh−5,793→ 28,614 total
Award
ARDELYX, INC.$ARDX
Stock Option (Right to Buy)
2023-06-15+49,237→ 49,237 total
Award
Intellia Therapeutics, Inc.$NTLA
Common Stock
2023-06-14+4,425→ 14,393 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2023-06-14+6,473→ 6,473 total
Award
VERACYTE, INC.$VCYT
Common Stock
2023-06-09+9,674→ 34,407 total
Sale
VERACYTE, INC.$VCYT
Common Stock
2023-05-30$25.91/sh−1,539→ 24,733 total
Award
CYTOKINETICS INC$CYTK
Common Stock
2023-05-10+5,000→ 16,031 total
Award
CYTOKINETICS INC$CYTK
Non-Qualified Stock Option (Right to Buy)
2023-05-10+10,000→ 10,000 total
Award
CYTOKINETICS INC$CYTK
Common Stock
2022-10-03$51.11/sh+220→ 11,031 total
Award
CYTOKINETICS INC$CYTK
Common Stock
2022-07-01$41.00/sh+274→ 10,811 total
Award
VERACYTE, INC.$VCYT
Common Stock
2022-06-16+14,731→ 26,272 total
Award
ARDELYX, INC.$ARDX
Stock Option (Right to Buy)
2022-06-15+100,000→ 100,000 total
Award
ARDELYX, INC.$ARDX
Common Stock
2022-06-15+95,802→ 95,802 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2022-06-14+2,980→ 2,980 total
Award
Intellia Therapeutics, Inc.$NTLA
Common Stock
2022-06-14+2,014→ 9,968 total
Award
CYTOKINETICS INC$CYTK
Common Stock
2022-05-10+5,000→ 10,537 total
Award
CYTOKINETICS INC$CYTK
Non-Qualified Stock Option (right to buy)
2022-05-10+10,000→ 10,000 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (Right to Buy)
2022-04-28+11,700→ 11,700 total

Companies

Recent Filings

Address

C/O ARDELYX, INC. 400 FIFTH AVENUE, SUITE 210

WALTHAM, MA, 02451

View on SEC.gov